B6d2f1 mice
B6D2F1 mice are a hybrid mouse strain that is commonly used in research. These mice are the result of a cross between C57BL/6 (B6) and DBA/2 (D2) mouse strains. B6D2F1 mice exhibit characteristics of both parental strains and are often used as a model organism in various research applications.
Lab products found in correlation
12 protocols using b6d2f1 mice
Genetically Modified Mouse Models of Prostate Cancer
Establishing Iron-Loaded Mouse Model
B6D2F1 Mice Study Protocol
Transgenic Mouse Breeding and Housing
Bone Marrow Transplantation in Mice
Example 76
Female C57BL/6 and B6D2F1 mice are purchased from the Jackson Laboratory (Bar Harbor, Me., USA). Bone marrow is harvested from the femurs and tibias of 12-20 week old mice. Before receiving transplantation, B6D2F1 mice are given 14 Gy total body irradiation (137Cs source). Irradiation is done twice, three hours apart. 5×10{circumflex over ( )}6 bone marrow cells are supplemented with 2×10{circumflex over ( )}6 nylon-wool nonadherent splenetic T cells from C57BL/6 mice and resuspended in Leibovitz's L15 medium (Life Technologies Inc., New York USA) and transplanted by tail vein infusion (0.25 mL) into B6D2F1 mice (Cooke K R, Gerbitz A, Crawford J M, Teshmia T, Hill G R, Tesolin A. Rossignol D P, Ferrara J L M, 2001. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-host leukemia after experimental bone marrow transplantation. The Journal of Clinical Investigation. 107:1581-1589).
Efficacy of Oncolytic HSV in NSG Mice
Bone Marrow Transplant in Mice
Example 76
Female C57BL/6 and B6D2F1 mice are purchased from the Jackson Laboratory (Bar Harbor, Me., USA). Bone marrow is harvested from the femurs and tibias of 12-20 week old mice. Before receiving transplantation, B6D2F1 mice are given 14 Gy total body irradiation (137Cs source). Irradiation is done twice, three hours apart. 5×10 6 bone marrow cells are supplemented with 2×10 6 nylon-wool nonadherent splenetic T cells from C57BL/6 mice and resuspended in Leibovitz's L15 medium (Life Technologies Inc., New York USA) and transplanted by tail vein infusion (0.25 mL) into B6D2F1 mice (Cooke K R, Gerbitz A, Crawford J M, Teshmia T, Hill G R, Tesolin A, Rossignol D P, Ferrara J L M 2001. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-host leukemia after experimental bone marrow transplantation. The Journal of Clinical Investigation. 107:1581-1589).
Athymic Nude Mice for Preclinical Studies
Controlled Environment for Mouse Study
B6D2F1 Mice Aerosol Infection Study
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!